SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies, today announced that Company Chief Executive Officer, Dr. Stephen Chang, will be a featured presenter at the annual Bio Investor Forum in San Francisco, October 17-19, 2006.
